Targeting the JNK Pathway for Therapeutic Benefit in CNS Disease
- 1 February 2002
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Drug Targets-CNS & Neurological Disorders
- Vol. 1 (1) , 31-49
- https://doi.org/10.2174/1568007023339472
Abstract
Abstract: The c-Jun N-terminal Kinase (JNK) pathway leading to c-Jun phosphorylation plays a causal role in apoptosis of isolated primary embryonic neurons and of multiple neuronal cell lines following a wide variety of stimuli. Activation of this pathway may also contribute to the neuronal atrophy and death that is associated with neurodegenerative pathological conditions including Alzheimers, Parkinsons, Huntingtons Diseases and stroke. Here, the data that providelinks between the activation of the JNK pathway and its potential to play an operative role in CNS disease are reviewed. Also included is the progress on development of inhibitors targeting the JNK pathway for therapeutic benefit.Keywords
This publication has 0 references indexed in Scilit: